Hyperion Therapeutics (HPTX)
Add to Watchlists Create an AlertHPTX Key Stats
| Income Statement | |
| Revenue TTM | 0.00 |
| Revenue Quarterly YoY Growth | |
| EPS Diluted TTM | -17.28 |
| EPS Diluted Quarterly YoY Growth | |
| Net Income TTM | -32.26M |
| Profitability | |
| Gross Profit Margin Quarterly | |
| Profit Margin Quarterly | |
| Dividend | |
| Dividend Yield | 0.00% |
| Payout Ratio TTM Pro | Go Pro |
| Current Valuation | |
| Market Cap | 423.89M |
| Enterprise Value | 386.13M |
| PE Ratio TTM | |
| PE 10 Pro | Go Pro |
| PEG Ratio | |
| Price / Book Value | 12.33 |
| Other | |
| Beta Pro | Go Pro |
| Debt to Equity Ratio | 0.3518 |
| Free Cash Flow | -6.597M |
| Return on Equity | |
HPTX News
- 5 Stocks Rising on Unusual Volume May 20
- HYPERION THERAPEUTICS INC Files SEC form 8-K, Other Events May 17
- Hyperion Therapeutics Added to NASDAQ Biotechnology Index (NBI) GlobeNewswire May 16
- HYPERION THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements... May 16
- HYPERION THERAPEUTICS INC Files SEC form 10-Q, Quarterly Report May 10
- Hyperion Therapeutics Announces First Quarter 2013 Operating Results GlobeNewswire May 9
- HYPERION THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financia... May 9
- Hyperion Therapeutics to Report First Quarter 2013 Financial Results After Marke... May 6
- 3 Healthcare Stock Stories for Thursday Perusal May 2
- Hyperion Therapeutics Receives Orphan Drug Exclusivity From FDA noodls May 2
HPTX Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Hyperion Therapeutics is up 0.00% over the last year vs S&P 500 Total Return up 27.77%, Puma Biotechnology up 184.5%, and Cambrex Corporation up 78.39%.
HPTX Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these HPTX related companies
Pro Ratings for HPTX
Pro Report PDF for HPTX
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.
Download HPTX Pro Report PDF
Pro Strategies Featuring HPTX
Did Hyperion Therapeutics make it into our Pro Portfolio Strategies?
HPTX Profile
Sector: Healthcare
Industry: Biotechnology
Other HPTX Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| HPTX | 21.15 | +0.62 | +3.02% | 423.89M |
